BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share



BioCryst Pharmaceuticals reported $-0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.


Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 -0.21 -0.28 May/02 2024
FY2023Q4 Dec/2023 -0.28 -0.25 -0.38 Feb/26 2024
FY2023Q3 Sep/2023 -0.19 -0.25 -0.23 Nov/02 2023
FY2023Q2 Jun/2023 -0.24 -0.23 -0.32 Aug/03 2023
FY2023Q1 Mar/2023 -0.28 -0.30 -0.4 May/03 2023
FY2022Q4 Dec/2022 -0.38 -0.13 -0.10 Feb/21 2023
FY2022Q3 Sep/2022 -0.23 -0.29 -0.33 Nov/01 2022
FY2022Q2 Jun/2022 -0.32 -0.36 -0.24 Aug/04 2022
FY2022Q1 Mar/2022 -0.40 -0.35 -0.36 May/05 2022
FY2021Q4 Dec/2021 -0.10 -0.31 -0.34 Jan/10 2022
FY2021Q3 Sep/2021 -0.33 -0.29 -0.26 Nov/03 2021
FY2021Q2 Jun/2021 -0.24 -0.25 -0.24 Aug/05 2021


Eps Change Date
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Chugai Pharma JPY 59.04 0.05 Jun/2025
Daiichi Sankyo JPY 46.03 0.28 Jun/2025
DBV Technologies EUR -1.55 0.25 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
Glaxosmithkline USD 0.35 0.24 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025